Medical Affairs and Stakeholder Engagement

We equip clients with the knowledge to make informed, impactful decisions.

We support life sciences and health technology companies in building effective medical affairs strategies and meaningful engagement with key stakeholders across healthcare systems. Our work helps clients strengthen scientific communication, support evidence-based dialogue, and navigate complex environments where clinical, policy, and market perspectives intersect.
Effective stakeholder engagement requires more than outreach alone. It depends on a clear understanding of the priorities, expectations, and decision-making roles of clinicians, experts, patient communities, payers, and other relevant actors. We help clients approach these interactions in a structured, credible, and context-sensitive way, grounded in scientific value and healthcare system realities.
Our approach is tailored to the product, therapeutic area, and market context, helping clients build trusted relationships, communicate value more effectively, and support informed decision-making throughout the product lifecycle.
  • Market research and feasibility studies
  • Competitive landscape and patient journey mapping
  • Provider, payer, patient insights
  • Commercialization and launch strategy
  • Value proposition development for products and solutions

    1

    Other Services

    Clinical Research and Evidence Generation

    We generate the data and insights that drive product development, approval, access, and system integration.

    • Clinical trials (Phase I–III)
    • Post-approval studies (Phase IV, RWE, registries, observational studies)
    • Systematic reviews and meta-analyses
    • Biostatistics, data management, advanced analytics
    • Patient-reported outcomes (PRO), quality of life research
    • Health economics and outcomes research (HEOR)
    • Comparative effectiveness, benefit-risk analysis
    Regulatory Strategy and Market Access

    We help clients navigate regulatory pathways and secure access for:

    • Pharmaceuticals
    • Medical devices
    • In vitro diagnostics
    • Digital health technologies

    Our services include:

    1. Regulatory strategy, dossier preparation, submission
    2. Local adaptation of global registration files
    3. Fast-track, orphan, and early access pathways
    4. Health authority engagement and negotiation
    5. Pricing strategy, cost-effectiveness, budget impact modeling
    6. Reimbursement submissions and negotiation support
    7. Value-based healthcare (VBHC) contracting and outcome-based payment models
    Market Research, Strategy, and Commercial Planning

    We equip clients with the knowledge to make informed, impactful decisions.

    • Market research and feasibility studies
    • Competitive landscape and patient journey mapping
    • Provider, payer, patient insights
    • Commercialization and launch strategy
    • Value proposition development for products and solutions
    Policy, Health System, and VBHC Project Support

    We help clients and governments improve healthcare policy, financing, and delivery.

    • Evidence generation to inform clinical guidelines, reimbursement, and policy
    • Methodological support for national guideline development
    • White papers, policy briefs, and technical reports
    • Healthcare financing and payment reform
    • Public health program evaluation and optimization
    • Digital health evaluation, integration, and scale-up
    • VBHC project design, pilot development, and management with payers, providers, and governments
    Special Focus: Pharmaceutical and Medtech Clients

    For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

    Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

    We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.